Stocks Health care GCAN

OTC · Health care

Greater Cannabis Company, Inc. (GCAN)

At June 30, 2026 it held $111 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch GCAN in 60 seconds

What Greater Cannabis Company, Inc. does

Greater Cannabis Company, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker GCAN.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Greater Cannabis Company, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 21, 2026
   Executive or director change 8-K
2. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.61 versus -$0.43.
3. July 31, 2026
   Form SC 14F1 filing SC 14F1
4. July 31, 2026
   Executive or director change 8-K
5. July 16, 2026
   Activist stake (5% or more) SCHEDULE 13D
6. July 6, 2026
   Form SC 14F1 filing SC 14F1
7. July 6, 2026
   Change in control 8-K
8. May 13, 2026
   Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.00 versus $0.00.
9. March 31, 2026
   Annual report 10-K · period to December 31, 2025Diluted EPS $0.00 versus $0.00.
10. November 12, 2025
    Quarterly report 10-Q · period to September 30, 2025Diluted EPS -$0.04 versus -$0.09.

Recent insider filings (Forms 3, 4 and 144): 7, the latest on July 16, 2026. Insider transactions on SEC

Who owns GCAN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about GCAN

What does Greater Cannabis Company, Inc. do?

Greater Cannabis Company, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker GCAN.

Is Greater Cannabis Company, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $879.7K.

When did Greater Cannabis Company, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 21, 2026.

Similar companies

Compare GCAN with

Compare GCAN with any company

Follow GCAN

Get an email when Greater Cannabis Company, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow GCAN: get an email when it files

Where the numbers come from

Financial figures are the values Greater Cannabis Company, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.